Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/28/2025

Clinical Manifestations of Rare Connective Tissue Disorders

Musculoskeletal and Vascular Manifestations

  • Musculoskeletal pain and weakness are common complaints that should be carefully elicited, along with morning stiffness, according to the American Thoracic Society 1, 2
  • Raynaud's phenomenon is one of the most common clinical manifestations, particularly in mixed connective tissue disease and systemic sclerosis, as noted by the American Thoracic Society 2
  • Photosensitivity may be present in certain subtypes, as reported by the American Thoracic Society 1, 2

Respiratory Symptoms

  • Progressive dyspnea on exertion is the most prominent and disabling symptom when interstitial lung disease develops, typically present for >6 months before presentation, according to the American Thoracic Society 1, 2
  • Nonproductive cough occurs in 40-50% of patients and may be paroxysmal, dry, and refractory to antitussive agents, as noted by the American Thoracic Society 1 and the American College of Chest Physicians 3
  • Fatigue, cough, or dyspnea on exertion are nonspecific symptoms that may hide behind other organ involvement or associated comorbidities like myopathy or cardiac disease, as reported by the European League Against Rheumatism 4, 5
  • Early but irreversible lung function loss can occur asymptomatically, making respiratory symptoms particularly concerning, according to the European League Against Rheumatism 4, 5

Dermatologic Features

  • Dry skin, eczema, and dystrophic nails with rapid nail growth are common, as noted by the American Academy of Pediatrics 6
  • Sparse or abnormal hair growth including wavy or curly scalp hair with sparse hair at temples, and sparse eyebrows (only 10% have normal eyebrows), as reported by the American Academy of Pediatrics 6
  • Hyperpigmentation and numerous acquired melanocytic nevi are striking features, with individuals potentially developing over 100 nevi as they age, according to the American Academy of Pediatrics 6
  • Keratosis pilaris (follicular hyperkeratosis of extremities and/or face) is seen in the majority of cases, as noted by the American Academy of Pediatrics 6

Gastrointestinal and Cardiovascular Manifestations

  • Weight loss, malaise, and fatigue may be noted, though fever is rare and suggests an alternative diagnosis, as reported by the American Thoracic Society 1, 2
  • Hypertrophic cardiomyopathy can occur in nearly 40% of individuals with cardio-facio-cutaneous syndrome, sometimes rapidly progressive and even resulting in death, according to the American Academy of Pediatrics 6

Neurological and Cognitive Features

  • Intellectual disability is present in 90-100% of individuals with certain rare subtypes like cardio-facio-cutaneous syndrome, as noted by the American Academy of Pediatrics 6
  • Seizures may occur and are often refractory to medications, requiring multiple anticonvulsants, according to the American Academy of Pediatrics 6
  • Gross motor delays tend to be more pronounced in early years, with mean age of independent walking around 3 years in affected individuals, as reported by the American Academy of Pediatrics 6

Ocular Manifestations and Physical Examination Findings

  • Dry eyes should be carefully elicited as part of Sjögren's overlap features, as noted by the American Thoracic Society 1, 2
  • "Velcro" crackles on chest auscultation are detected in >80% of patients with interstitial lung disease, typically dry, end-inspiratory, and most prevalent in lung bases, according to the American Thoracic Society 1, 2
  • Clubbing is noted in 25-50% of patients with progressive pulmonary involvement, as reported by the American Thoracic Society 1, 2

Critical Pitfalls to Avoid

  • Do not dismiss nonspecific symptoms like fatigue, mild dyspnea, or arthralgias as benign, as early but irreversible organ damage (particularly lung fibrosis) can occur asymptomatically in the first 5-7 years after disease onset, and maintaining high clinical suspicion for interstitial lung disease is essential even when systemic symptoms appear mild, as noted by the European League Against Rheumatism 4, 5